Recursion Pharmaceuticals, Inc. (RXRX)
4.85
+0.16
(+3.41%)
USD |
NASDAQ |
Jan 14, 16:00
4.85
0.00 (0.00%)
After-Hours: 07:31
Recursion Pharmaceuticals SG&A Expense (TTM): 220.12M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Hims & Hers Health, Inc. | 1.147B |
| XOMA Royalty Corp. | 32.68M |
| Mirum Pharmaceuticals, Inc. | 239.73M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Amicus Therapeutics, Inc. | 353.07M |